1. Sweden

2. (Click on the graphs under each topic) Diagnostic Substitution
SWEDEN
(Click on the graphs under each topic)
AD Rate
AD Changepoints
Vaccines
MMR
Varicella
N/A
N/A
Polio
Hep A
N/A
Diagnostic Substitution
Paternal Age
Thimerosal
N/A
N/A
N/A

3. Birth Year AD prevalence (%) Normalized AD* 1998 2003 2007
Go back to main page
Birth Year
AD prevalence (%)
Normalized AD*
1998
0.12
0.23
2003
0.04
0.07
2007
0.52 1

4. (Click on the graphs under each topic)
Go back to main page
MMRII Vaccines
(Click on the graphs under each topic)
MMRII immunization coverage for Birthyear 1981 to 2008
MMRII coverage and AD prevalence in Sweden

5. MEASLES, MUMPS, RUBELLA, VARICELLA
Data
MMR main page
Go back to main page
MEASLES, MUMPS, RUBELLA, VARICELLA
1982
MMR II
Combined measles, mumps and rubella with the RA 27/3 strain
>=12 months
Licensed

6. MMR main page
Go back to main page
Birthyear
MMR coverage
1981
89.7
1982
91.1
1983
92.7
1984
93.6
1985
94.2
1986 94
1987
94.3
1988
94.7
1989
95.1
1990
95.7
1991
95.8
1992
96.2
1993
96.5
1994
96.8
1995
96.6
1996
96.3
1997
95.5
1998
1999
88.5
2000
90.5
2001
93.5
2002
94.5
2003
95.4
2004
2005
2006
96.7
2007
2008
96.4

7. MMR main page
Go back to main page

8. POLIO VACCINES * There is no polio vaccine that uses MRC-5 cell line.
Go back to main page
POLIO VACCINES
Cells
Type of Vaccine
Company
Approval
Trade Name
Vero cell line  
DTacP-IPV/Hib
Sanofi Pasteur
1997
Pentaxim
DTacP-IPV
1998
Tetraxim
* There is no polio vaccine that uses MRC-5 cell line.